University of Chicago Radiation Oncology

Very grateful for the opportunity and the great mentorship at @UChicagoRadonc. Special thanks to @RohanKatipally for all the support!

Proud of superstar resident, Dr. Abed Kawakibi @AbedKawakibi, presenting how ctDNA may improve surveillance of HPV+ oropharyngeal cancer after chemoradiation at @ASTRO_org — work emerging from treatment de-escalation protocols at our UChicago Head & Neck Cancer Program!

Congrats to our very own Steve Chmura (@Docace911) for his role on the @AACR Cancer Progress Report 2025 Steering Committee! #radonc #cancer

UChicago is recruiting for a faculty radiation oncologist position. We'll be meeting candidates at ASTRO 2025. Check out our posting: apply.interfolio.com/169586 EEO/Vet/Disability #radonc #ASTRO

UChicago is recruiting for a faculty radiation oncologist position. We'll be meeting candidates at ASTRO 2025. Check out our posting: careers.astro.org/jobs/view/facu… #radonc #ASTRO

Check out the excellent perspective published by Sean Pitroda, MD, and colleagues in @NatureGenet, highlighting how high aneuploidy scores predict immunotherapy response and can help guide personalized cancer treatment. @UChicagoRadonc @UChicagoMed ow.ly/bJ7K50WkwMf

New study from @rweichselbaum and team show high-dose radiation triggers amphiregulin, a protein that weakens immunity and fuels distant cancer spread—pointing to new strategies for blocking its effects. @SeanPitroda @AndrasPiffko @UChicagoRadonc @Nature ow.ly/HgVU50Wn6ZY

Excited to share our recent @Nature paper! nature.com/articles/s4158… Tremendous collaborative effort from @UCCancerCenter @UChicago @UChicagoRadonc @rweichselbaum

Facts and hopes in radioimmunotherapy of oligometastatic disease aacrjournals.org/clincancerres/… Excellent review by @UChicagoRadonc residents Daniel Huang and Connor Lynch @rweichselbaum @UCCancerCenter

@UMichRadOnc And here is Dr. Lawrence with our chair, @rweichselbaum.

Terrific visit today from @UMichRadOnc 's Dr. Ted Lawrence, pictured here with our Rad Onc residents.

Congrats to our incoming Chief Resident @J0hnMWhite for his EAGL honors!

April marks #NationalCancerControlMonth. Cancer screenings can provide early detection and can help control cancers at their earliest and most treatable stages. @UChicagoMed @UChicagoHemOnc @UChicagoBreast @UChicagoRadonc @UChicagoOHNS

We are thrilled to announce our newly-matched 2030 class of radiation oncology residents: Chad Caraway, Alexander Cooke, and Azan Haque. Welcome! @HaqueAzan

Where does #immunotherapy stand in the treatment of metastatic cancers? Is it the only and best choice? Check out the insights shared by @UChicagoRadonc experts @rweichselbaum and @SeanPitroda here: ow.ly/e1rh50SYn8i @UChicagoMed @UCCancerCenter @UChicagoHemOnc

Great work by PGY5 resident @ConnorLynchMD on pooling and reporting on prospectively collected clinical trial data to guide clinicians on the safety of multi-site SBRT and immunotherapy in patients with metastatic disease @UCCancerCenter @UChicagoRadonc sciencedirect.com/science/articl…

New Review in the August issue: Radiotherapy, immunity, and immune checkpoint inhibitors #radiotherapy #ImmuneCheckpointInhibitors thelancet.com/journals/lanon…

Another fantastic article written by the extremely talented @ConnorLynchMD ! thelancet.com/journals/lanon… @rweichselbaum @TheLancetOncol @Ludwig_Cancer @UChicago @UCCancerCenter @UChicagoRadonc

Aditya Jullori, MD chairs a Clinical Science Symposium Session - “Making the Cut: Decision Support Tools in Surgically Treated HPV+ Oropharyngeal Cancer.” #ASCO24 @ajuloorimd @UChicagoRadonc @UChicagoOHNS @UCCancerCenter @UChicagoHemOnc